Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2

Title
Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
Authors
Keywords
PD-1, PD-L1, PD-L2, small-molecule inhibitor, cancer, immunotherapy, therapeutic antibody, immune checkpoint, nivolumab, pembrolizumab
Journal
STRUCTURE
Volume 25, Issue 8, Pages 1163-1174
Publisher
Elsevier BV
Online
2017-08-02
DOI
10.1016/j.str.2017.06.011

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started